IFF - International Flavors & Fragrances Inc.

IFF

$75.10 +0.00 (+0.00%)

Pre-Market: $74.67 0.43 (-0.57%)

Last updated: Jul 15, 2026 09:20

52-Week Range

$74.67

$59.14 $74.67 $84.45

Fundamentals Overview

International Flavors & Fragrances Inc. is in the middle of its 52-week range with moderate valuation, trading relatively flat today.

Valuation moderate

P/E 22.5 PEG 0.11 P/B 1.35 P/S 1.77

Intrinsic value (DCF)

-96.2% downside vs price

Profitability

Net margin 7.9%

Risk (Beta)

0.94 — in line vol

Earnings & growth

EPS $3.32 Rev +5.9% Profit +445.2% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 55% confidence Risk: Moderate Volatility — Beta 0.94. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B · Sentiment improving (2 upgrades) · 3M vs Basic Materials sector: +7.1%

Pressures (Sell):

DCF 96.2% downside vs price · 3M vs S&P 500: -5.4%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$19.06B

P/E (TTM)

22.52

EPS (TTM)

$3.32

Dividend Yield

2.14%

52-Week Range

$59.14 - $84.45

Volume vs Avg

N/A

Beta

0.94

About

International Flavors & Fragrances Inc. (IFF), through its various subsidiaries, operates as a global developer and purveyor of active cosmetic and natural health ingredients. These vital components are incorporated into a wide array of consumer goods distributed across significant markets such as Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. The company's activities are organized into four principal divisions: 1. Nourish: This segment focuses on natural and pl...

Sector: Basic Materials

Headquarters: US

Employees: 21,500

IPO Date: Dec 1974

Website: www.iff.com

Beta: 0.94 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 11, Neutral: 4, Outperform: 6, Overweight: 8, Peer Perform: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $2.86; current price is $74.67. That’s a -96.2% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	22.52
DCF value (model)	$2.86 (-96.2% vs price)
PEG (TTM)	0.11
P/B (TTM)	1.35
P/S (TTM)	1.77
P/FCF (TTM)	47.9
Liquidity & enterprise
Current Ratio (TTM)	1.49
Quick Ratio (TTM)	0.84
Cash Ratio (TTM)	0.15
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	7.9%
Gross margin (TTM)	36.35%
Operating margin (TTM)	7.56%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for IFF.

Analyst Sentiment at a Glance

B Sentiment Improving

Buy 11Neutral 4Outperform 6Overweight 8Peer Perform 1

2 upgrades, 0 downgrades

Price Target Consensus

Current $74.67

Median $90.00

Consensus $88.38

Low consensus $75.00

High consensus $95.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
Morgan Stanley	maintain	Overweight	Overweight	2026-07-01
Argus Research	maintain	Buy	Buy	2026-06-30
Citigroup	maintain	Buy	Buy	2026-06-24
Barclays	maintain	Overweight	Overweight	2026-05-08
JP Morgan	maintain	Overweight	Overweight	2026-05-07
Oppenheimer	maintain	Outperform	Outperform	2026-05-07
Citigroup	maintain	Buy	Buy	2026-05-07
Oppenheimer	maintain	Outperform	Outperform	2026-04-22
Barclays	maintain	Overweight	Overweight	2026-04-14
Citigroup	maintain	Buy	Buy	2026-04-13
UBS	maintain	Neutral	Neutral	2026-04-09
Barclays	maintain	Overweight	Overweight	2026-02-17
Mizuho	maintain	Outperform	Outperform	2026-02-17
Wells Fargo	maintain	Overweight	Overweight	2026-02-13
Oppenheimer	upgrade	Perform	Outperform	2026-02-13
Citigroup	maintain	Buy	Buy	2026-02-13
Mizuho	maintain	Outperform	Outperform	2026-02-12
Argus Research	maintain	Buy	Buy	2026-01-22
Citigroup	maintain	Buy	Buy	2026-01-21
UBS	maintain	Neutral	Neutral	2026-01-12
Barclays	maintain	Overweight	Overweight	2025-11-07
UBS	maintain	Neutral	Neutral	2025-11-06
B of A Securities	maintain	Buy	Buy	2025-10-14
Argus Research	maintain	Buy	Buy	2025-10-07
UBS	maintain	Neutral	Neutral	2025-10-06
Citigroup	maintain	Buy	Buy	2025-10-06
Mizuho	maintain	Outperform	Outperform	2025-10-03
Morgan Stanley	maintain	Overweight	Overweight	2025-09-22
Wolfe Research	upgrade	Underperform	Peer Perform	2025-09-08
Tigress Financial	maintain	Buy	Buy	2025-08-26